Related Experiment Video
Updated: Jul 18, 2026

12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib
Silke C Hofmann1, Kristin Technau, Antonia M S Müller
1Department of Dermatology, University of Freiburg Freiburg, Germany.
Journal of the American Academy of Dermatology
|November 14, 2006
Abstract:
Hypereosinophilic syndrome is a myeloproliferative disorder defined by unexplained, persistent hypereosinophilia with cutaneous or systemic involvement. We describe a patient with coexistence of hypereosinophilic syndrome and bullous pemphigoid. Treatment with the novel tyrosine kinase inhibitor imatinib mesylate resulted in durable remission of hypereosinophilia and skin lesions.